However, P38 inhibits downregulation of Akt and ERK phosphorylation levels, thereby promoting their activity, proliferation, and invasion in cholangiocarcinoma cells, and conversely, PTPRJ has been shown to recognize the receptor PTK Met as a substrate [42,48,59,60]. Here, MET is linked to cholangiocarcinoma.